Journal
MOLECULAR MEDICINE REPORTS
Volume 4, Issue 3, Pages 459-464Publisher
SPANDIDOS PUBL LTD
DOI: 10.3892/mmr.2011.460
Keywords
autophagy; advanced glycation end-product-modified bovine scrum albumin; reactive oxygen species; human umbilical vein endothelial cells; injury
Categories
Funding
- Plans for Graduate Research and Innovation in Colleges and Universities of Jiangsu Province [CX09B_036Z]
- National Natural Science Foundation of China [30870869]
Ask authors/readers for more resources
Advanced glycation end-products (AGEs) contribute to the pathogenesis of diabetes mellitus and atherosclerosis by promoting vascular endothelial cell proliferation, migration, damage and death. In this study, we examined the role of autophagy in HUVECs exposed to AGE-modified bovine serum albumin (AGE-BSA). HUVECs incubated with AGE-BSA for 6 h showed an increase in the formation of acidic vesicular organelles and autophagosomes. AGE-BSA-induced upregulation of microtubule associated protein 1 light chain 3-II (LC3-II), a marker of autophagy, was abolished by pretreatment with the autophagy inhibitor 3-methyladenine (3-MA), and was increased by rapamycin, an autophagy inducer. The increase of lactate dehydrogenase (LDH) leakage induced by AGE-BSA was increased by 3-MA, but not rapamycin. An oxidative inhibitor, a-tocopherol, decreased not only the AGE-BSA-induced increase of reactive oxygen species, but also the upregulation of LC3-II protein levels. These results suggest that AGE-BSA increases the level of autophagy, which is protective against HUVEC injury, and that ROS play a role in this activation of autophagy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available